Month: May 2022

May 31, 2022May 31, 2022

Neoadjuvant immune checkpoint inhibitors in high-risk stage III melanoma.

Melanoma Literature

Publication date: May 31, 2022 The success of immunotherapy and targeted therapy for metastatic melanoma has generated considerable interest in the adjuvant setting, even though high-risk stage III melanoma (with ... Read more

May 31, 2022May 31, 2022

Intratumoral therapies and in-situ vaccination for melanoma.

Melanoma Literature

Publication date: May 31, 2022 Skin cancers are among the most physically accessible malignancies, so local delivery of a medication into the tumor, so-called intratumoral therapy, is an appealing route ... Read more

May 31, 2022May 31, 2022

T cell Egress via Lymphatic Vessels Limits the Intratumoral T cell Repertoire in Melanoma

Melanoma News

Publication date: May 29, 2022 Antigen-specific CD8+ T cell accumulation in tumors is a prerequisite for effective immunotherapy, and yet, the mechanisms of lymphocyte transit remain poorly defined. We find ... Read more

May 30, 2022May 30, 2022

“Fluorescent sensor paint” lights up key markers of Parkinson's disease

Parkinson's Disease News

Publication date: May 30, 2022 The technique begins with ultra-thin carbon nanotubes around 10,000 times thinner than a human hair. Concepts Keywords Decades Machine learning Germany Fast-scan cyclic voltammetry Lab ... Read more

May 29, 2022May 29, 2022

Androgen Receptor is a Determinant of Melanoma Targeted Drug Resistance

Melanoma News

Publication date: May 27, 2022 Melanoma provides a primary benchmark for targeted drug therapy. Most melanomas with BRAFV600 mutations regress in response to BRAF/MEK inhibitors (BRAFi/MEKi). However, nearly all relapse ... Read more

May 29, 2022May 29, 2022

EORTC and Pierre Fabre launch phase 3 trial for melanoma

Melanoma News

Publication date: May 29, 2022 The European Organisation for Research and Treatment of Cancer (EORTC) and health and beauty care company, Pierre Fabre, have begun a phase 3 study to ... Read more

May 28, 2022May 28, 2022

Lymph node colonization induces tumor-immune tolerance to promote distant metastasis.

Melanoma Literature

Publication date: May 26, 2022 For many solid malignancies, lymph node (LN) involvement represents a harbinger of distant metastatic disease and, therefore, an important prognostic factor. Beyond its utility as ... Read more

May 28, 2022May 28, 2022

Clinical trials investigating the treatment of melanoma

Melanoma Media

May 28, 2022May 28, 2022

Precision Oncology: DecisionDx®-Melanoma and the Evolution of GEP Testing in Cutaneous Melanoma

Melanoma Media

May 28, 2022May 28, 2022

Directional Deep Brain Stimulation With Patients With Advanced Parkinson's Disease

Parkinson's Disease News

Publication date: May 27, 2022 The aim of the study is to assess the clinical outcome in patients with Parkinson’s disease treated with directional deep brain stimulation (dDBS). The patients ... Read more